Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Study Title
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
Teva Identifier
TVP-1012/PM101
ClinicalTrials.gov Identifier
NCT00399477
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: rasagiline mesylate |Drug: Rasagiline mesylate plus Mirapex | Drug: Rasagiline mesylate with Levodopa | Drug: Rasagiline mesylate with Requip

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
30 Years and older
Trial Duration
10/01/2006 - 07/01/2007
Phase
Phase 4

Study Type

Interventional